期刊文献+

肠球菌感染的临床调查 被引量:21

Clinical survey of enterococcal infections
下载PDF
导出
摘要 目的 :了解肠球菌所致感染的概况及其对抗菌药的敏感性。方法 :调查与分析复旦大学附属华山医院 1998年 6月~1999年 3月临床分离获肠球菌住院患者的临床资料 ,用KB法测定细菌药敏。结果 :116例患者中 ,属医院感染、院外感染者分别为 37和 13例 ,带菌者 6 6例 ,感染部位多为尿路 (6 4% )、次为腹腔 (18% ) ,粪肠球菌 (6 4% )多于屎肠球菌 (36 % )。患严重基础疾病、接受介入诊疗操作、应用广谱抗菌药可能是肠球菌医院感染的危险因素。药敏结果显示 :氨苄西林、万古霉素对肠球菌抗菌活性相对较高 ,抑菌率分别为 75 .8%和 96 .9% ,屎肠球菌耐药率高于粪肠球菌。结论 :肠球菌已成为医院感染患者主要病原菌之一 ,及时、合理诊治是治愈该类感染的关键。 Objective:To investigate the prevalence of enterococcal infection and the susceptibility of Enterococcus spp.to antibacterial agents. Methods:The medical history of 116 hospitalized patients from whom Enterococcus spp were isolated during the period of June 1998-March 1999 were reviewed. Bacterical susceptibility testing were done by Kirby-Bauer method. Results: Out of 116 patients, 50 were patients with enterococcal infections, (nosocomial infection in 37, community infection in 13,) and 66 were carriers. The most common sites of infection were urinary tract (64%), abdominal cavity(18%) being the second. Among Enterococcus spp, E. faecalis accounted for 64%, E. faecium 36%. Severe underlying diseases, accepting intervention procedures and use of broad spectrum antibiotics were common risk factors. Vancomycin and ampicillin were the most active agents against enterococcal isolates, inhibition rates being 96.9% and 75.8% respectively. Strains of E. faecium were more resistant than strains of E. faecalis . Conclusions: Enterococcus spp. become one of the major pathogens in nosocomial infections. Early diagnosis and rational treatment is the key to improve the outcome of these patients.
出处 《中国抗感染化疗杂志》 2001年第2期83-86,共4页 Chinese Journal of Infection and Chemotherapy
关键词 肠球菌感染 临床调查 药物敏感性 KB法 医院感染 病原菌 诊断标准 Enterococcus Bacterial infection Antibacterial agents
  • 相关文献

参考文献4

  • 1Edmond MB,Wallace SE,McClish DK,et al.Nosocomial bloodstream infections in United States hospitals:a three-year analysis[J].Clin Infect Dis,1999,29(2):239-244.
  • 2Moellering RC. Emergence of enterococcus as a significant pathogen[J]. Clin Infect Dis, 1992,14(6):1173-1176.
  • 3Gaynes R,Edwards J. National Nosocomial Infection Surveillance(NNIS) System.Nosocomial vancomycin resistant enterococci(VRE) in the United States,1989-1995:the first 1000 isolates[J]. Infect Control Hosp Epidemiol, 1996,17(Suppl):18.
  • 4汪复,朱德妹,张婴元.上海部分医院细菌耐药性监测及其临床意义[J].中华传染病杂志,1996,14(3):148-151. 被引量:101

二级参考文献4

  • 1汪复,Drugs,1993年,45卷,增3期,170页
  • 2朱德妹,中华医学杂志,1992年,72卷,595页
  • 3魏明谦,中华传染病杂志,1991年,9卷,14页
  • 4朱德妹,中华传染病杂志,1988年,6卷,2页

共引文献100

同被引文献111

  • 1胡龙华,贾坤茹,陈东红,胡晓彦,徐建民,桂炳东.临床分离的肠球菌株耐药性变迁分析[J].中华医院感染学杂志,2004,14(8):944-946. 被引量:30
  • 2袁瑾,邓小明,刘海云.呼吸道感染嗜麦芽寡养单胞菌的临床及耐药分析[J].中华医院感染学杂志,2005,15(6):702-704. 被引量:27
  • 3李淑美.仙力素治疗急性支气管肺炎96例观察[J].山东医药,2005,45(22):85-85. 被引量:5
  • 4沈宗坤,于淑玲,梅影.医院内革兰阳性球菌感染的调查及耐药分析[J].实用医技杂志,2007,14(6):676-678. 被引量:1
  • 5李仲兴 郑家齐.诊断细菌学[M].香港:黄河文化出版社,1992.295-297.
  • 6MONGODIN E, FINAN J, CLIMO M W, et al. Microarray tran- scription analysis of clinical staphylococcus aurous isolates resistant to vancomycin[ J]. J Bacterial, 2003, 185(15) : 4 638 -4 643.
  • 7[17]Boarett M, Canepari P. Purification of daptomycin bingding proteins (DPBS) from the membrane of Enterococcus hirae. New Microbiol, 2000, 23:305~317
  • 8[18]Canepari P, Boarett M. Lipoteichoic acid as a target for antimicrobial action. Microb Drug Resist, 1996,2:85~89.
  • 9[19]Akins RL, Rybak MJ. In vitro activities of daptomycin arbekacin vancomycin and gentamicin alone and/or in combination against glycopeptide intermediate-resistant ataphylococcus aureus in an infection mode1 .Antimicrob Agents Chemother , 2000 , 44:1925~1929
  • 10[20]Dever Lise L et al. Expert Opin Invest Druge, 2001: 10 (2):353

引证文献21

二级引证文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部